Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B

Huang,Rengang; Jiang,Nan; Yang,Renguo; Geng,Xiaoxia; Lin,Jianmei; Xu,Gang; Liu,Dandan; Chen,Jidog; Zhou,Guo; Wang,Shuqiang; Luo,Tingting; Wu,Jiazhen; Liu,Xiaoshu; Xu,Kaiju; Yang,Xingxiang

doi:10.3892/etm.2016.3135

Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B

Authors:
- Rengang Huang
- Nan Jiang
- Renguo Yang
- Xiaoxia Geng
- Jianmei Lin
- Gang Xu
- Dandan Liu
- Jidog Chen
- Guo Zhou
- Shuqiang Wang
- Tingting Luo
- Jiazhen Wu
- Xiaoshu Liu
- Kaiju Xu
- Xingxiang Yang
View Affiliations

Affiliations: Department of Infectious Disease, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China, Department of Pathology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China, Department of Medical Ultrasonics, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China
Published online on: March 9, 2016 https://doi.org/10.3892/etm.2016.3135
Pages: 1673-1677
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the diagnostic accuracy of Fibroscan for liver fibrosis in patients with chronic hepatitis B (CHB) with alanine aminotransferase (ALT) levels <2 times the upper normal limit. A total of 263 consecutive patients with CHB and ALT levels <2 times the upper normal limit were enrolled in the present study. Liver biopsies and liver stiffness measurements (LSM) were conducted. Receiver operating characteristic (ROC) analysis was used to determine the predictive ability of LSM for the development of liver fibrosis in patients with stage S1, S2 and S3 liver fibrosis. Bivariate Spearman rank correlation analysis was performed in order to determine the association between liver stiffness value, which was measured by Fibroscan, and liver fibrosis stage, which was measured by liver biopsy. The liver stiffness value was found to be positively correlated with the liver fibrosis stage (r=0.522, P<0.001) and necroinflammatory activity (r=0.461, P<0.001), which was measured by liver biopsy. The optimal cut‑off value in the patients with stage S1, S2 and S3 liver fibrosis was 5.5, 8.0 and 10.95 kPa, respectively. The area under the ROC curve for the prediction of the development of liver fibrosis in these patients was 0.696, 0.911 and 0.923, respectively. The threshold of the optimal cut‑off value exhibited a high sensitivity and specificity. The results of the present study suggested that Fibroscan may improve the sensitivity of the diagnosis of liver fibrosis in patients with CHB and ALT levels <2 times the upper normal limit, and that this sensitivity may increase with the progression of liver fibrosis.

View Figures

View References

1	Williams MJ, Clouston AD and Forbes SJ: Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology. 146:349–356. 2014. View Article : Google Scholar : PubMed/NCBI
2	Friedman SL: Liver fibrosis-from bench to bedside. J Hepatol. 38(Suppl 1): S38–S53. 2003. View Article : Google Scholar : PubMed/NCBI
3	Lok AS and McMahon AJ: Chronic hepatitis B. Hepatology. 45:507–539. 2007. View Article : Google Scholar : PubMed/NCBI
4	Croagh CM and Lubel JS: Natural history of chronic hepatitis B: Phases in a complex relationship. World J Gastroenterol. 20:10395–10404. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ginès P, Cárdenas A, Arroyo V and Rodés J: Management of cirrhosis and ascites. N Engl J Med. 350:1646–1654. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011. View Article : Google Scholar : PubMed/NCBI
7	Rockey DC, Caldwell SH, Goodman ZD, Nelson RC and Smith AD: American Association for the Study of Liver Diseases: Liver biopsy. Hepatology. 49:1017–1044. 2009. View Article : Google Scholar : PubMed/NCBI
8	Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR and Schiff ER: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 97:2614–2618. 2002. View Article : Google Scholar : PubMed/NCBI
9	Bravo AA, Sheth SG and Chopra S: Liver biopsy. N Engl J Med. 344:495–500. 2001. View Article : Google Scholar : PubMed/NCBI
10	Bedossa P, Dargère D and Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 38:1449–1457. 2003. View Article : Google Scholar : PubMed/NCBI
11	Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, Kumar A, Matin A and Arora A: The usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol. 33:445–451. 2014. View Article : Google Scholar : PubMed/NCBI
12	Castera L, Forns X and Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 48:835–847. 2008. View Article : Google Scholar : PubMed/NCBI
13	Enomoto M, Morikawa H, Tamori A and Kawada N: Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol. 20:12031–12038. 2014. View Article : Google Scholar : PubMed/NCBI
14	Sporea I, Gilja OH, Bota S, Şirli R and Popescu A: Liver elastography - an update. Med Ultrason. 15:304–314. 2013. View Article : Google Scholar : PubMed/NCBI
15	Lee S and Kim Do Y: Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol. 20:445–459. 2014. View Article : Google Scholar : PubMed/NCBI
16	Wu T, Li L, Wang H, Luo X and Ning Q: Transient elastography in hepatitis B virus infection. Liver stiffness discrepancy due to sampling location. Saudi Med J. 35:554–560. 2014.PubMed/NCBI
17	Bota S, Sporea I, Peck-Radosavljevic M, Sirli R, Tanaka H, Iijima H, Saito H, Ebinuma H, Lupsor M, Badea R, et al: The influence of aminotransferase levels on liver stiffness assessed by acoustic radiation force impulse elastography: A retrospective multicentre study. Dig Liver Dis. 45:762–768. 2013. View Article : Google Scholar : PubMed/NCBI
18	Pratt DS and Kaplan MM: Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 342:1266–1271. 2000. View Article : Google Scholar : PubMed/NCBI
19	Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, et al: Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 137:1–10. 2002. View Article : Google Scholar : PubMed/NCBI
20	Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, et al: Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol. 56:55–62. 2012. View Article : Google Scholar : PubMed/NCBI
21	Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H and Bedossa P: FIBROSTIC Study Group: Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol. 53:1013–1021. 2010. View Article : Google Scholar : PubMed/NCBI
22	Trembling PM, Lampertico P, Parkes J, Tanwar S, Viganò M, Facchetti F, Colombo M and Rosenberg WM: Performance of enhanced liver fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 21:430–438. 2014. View Article : Google Scholar : PubMed/NCBI
23	Reitman S and Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63. 1957. View Article : Google Scholar : PubMed/NCBI
24	Cohen-Naftaly M and Friedman SL: Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 4:391–417. 2011. View Article : Google Scholar : PubMed/NCBI
25	Lefkowitch JH: Liver biopsy assessment in chronic hepatitis. Arch Med Res. 38:634–643. 2007. View Article : Google Scholar : PubMed/NCBI
26	Cadranel JF, Rufat P and Degos F: Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 32:477–481. 2000. View Article : Google Scholar : PubMed/NCBI
27	Papastergiou V, Tsochatzis E and Burroughs AK: Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 25:218–231. 2012.PubMed/NCBI
28	Chen YP, Liang XE, Dai L, Zhang Q, Peng J, Zhu YF, Wen WQ, Chan HL and Hou JL: Improving transient elastography performance for detecting hepatitis B cirrhosis. Dig Liver Dis. 44:61–66. 2012. View Article : Google Scholar : PubMed/NCBI
29	Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, Chan FK, Sung JJ and Wong VW: Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 16:36–44. 2009. View Article : Google Scholar : PubMed/NCBI
30	Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, Bower M, Gazzard B and Nelson M: A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol. 44:214–219. 2010. View Article : Google Scholar : PubMed/NCBI
31	Liu Y, Dong CF, Yang G, Liu J, Yao S, Li HY, Yuan J, Li S, Le X, Lin Y, et al: Optimal linear combination of ARFI, transient elastography and APRI for the assessment of fibrosis in chronic hepatitis B. Liver Int. 35:816–825. 2015. View Article : Google Scholar : PubMed/NCBI
32	Lee MH, Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Yang JM, Han KH and Cho SW: Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci. 55:3552–3560. 2010. View Article : Google Scholar : PubMed/NCBI